Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05869890 · ClinicalTrials.gov registry record · NA
Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi
A NA study, sponsored by Albany Medical College.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05869890: Clinical Trial NA study, sponsored by Albany Medical College.
NCT05869890 is a NA study that was terminated before completion, run by Albany Medical College. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05869890, a NA study, was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will examine the effects of ureteroscopic lasing technique (dusting, fragmentation and a hybrid approach) on total lasing time and total energy in patients with a large renal calculi burden of single or multiple stones with the sum of its longest diameters between 10-20 mm and having mean Hounsfield units of 1000 or more.
Primary Outcome
Hybrid technique will result in overall reduced OR time
Interventions
- DEVICE MOSES laser system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-02-22 |
| Est. Completion | 2024-08-27 |
| Phase | NA |
Why NCT05869890 stopped before completion
NCT05869890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which MOSES laser system is the first listed.
NCT05869890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05869890 about?
NCT05869890 is a clinical study titled "Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi". This study will examine the effects of ureteroscopic lasing technique (dusting, fragmentation and a hybrid approach) on total lasing time and total energy in patients with a large renal calculi burden of single or multiple stones with the sum of its longest diameters between 10-20 mm and having mean...
What is the current status of trial NCT05869890?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-02-22. Estimated completion is 2024-08-27.
What interventions are being tested in trial NCT05869890?
The interventions under investigation include: MOSES laser system (DEVICE).
Who is sponsoring clinical trial NCT05869890?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05869890's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI